Liver immune secrets: how chemo affects eye cancer spread
NCT ID NCT07364474
First seen Jan 26, 2026 · Last updated Apr 30, 2026 · Updated 14 times
Summary
This study looks at how the liver's immune system responds to a chemotherapy drug called melphalan, given directly to the liver through a procedure called Percutaneous Hepatic Perfusion (PHP). It involves 10 people with uveal melanoma that has spread to the liver. The goal is to understand immune changes in the tumor, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEAL MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.